Clinical Trials

NCT04538755 | ENROLLING_BY_INVITATION | PHASE1/PHASE2
20 participants

DAW2020 on OSA Endotypic Traits

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-15
Start Date:
2020-11-15
Completion:
2025-05-15
Conditions
  • Obstructive Sleep Apnea (OSA)
Interventions
  • DRUG
No Results Yet
NCT04441554 | RECRUITING
600 participants

7 Tesla MRI Evaluation of the Spine

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-15
Start Date:
2020-03-04
Completion:
2027-09-30
Conditions
  • Magnetic Resonance Imaging
  • Cervical Spine Disease
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04284774 | ACTIVE_NOT_RECRUITING | PHASE2
5 participants

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-15
Start Date:
2020-10-13
Completion:
2024-03-31
Conditions
  • Malignant Solid Neoplasm
  • Recurrent Adrenal Gland Pheochromocytoma
  • Recurrent Ectomesenchymoma
  • Recurrent Ependymoma
  • Recurrent Ewing Sarcoma
  • Recurrent Hepatoblastoma
  • Recurrent Kidney Wilms Tumor
  • Recurrent Langerhans Cell Histiocytosis
  • Recurrent Malignant Germ Cell Tumor
  • Recurrent Malignant Glioma
  • Recurrent Medulloblastoma
  • Recurrent Melanoma
  • Recurrent Neuroblastoma
  • Recurrent Non-Hodgkin Lymphoma
  • Recurrent Osteosarcoma
  • Recurrent Peripheral Primitive Neuroectodermal Tumor
  • Recurrent Rhabdoid Tumor
  • Recurrent Rhabdoid Tumor of the Kidney
  • Recurrent Rhabdomyosarcoma
  • Recurrent Soft Tissue Sarcoma
  • Recurrent Thyroid Gland Carcinoma
  • Recurrent WHO Grade 2 Glioma
  • Refractory Adrenal Gland Pheochromocytoma
  • Refractory Ependymoma
  • Refractory Ewing Sarcoma
  • Refractory Hepatoblastoma
  • Refractory Langerhans Cell Histiocytosis
  • Refractory Malignant Germ Cell Tumor
  • Refractory Malignant Glioma
  • Refractory Medulloblastoma
  • Refractory Melanoma
  • Refractory Neuroblastoma
  • Refractory Non-Hodgkin Lymphoma
  • Refractory Osteosarcoma
  • Refractory Peripheral Primitive Neuroectodermal Tumor
  • Refractory Rhabdoid Tumor
  • Refractory Rhabdoid Tumor of the Kidney
  • Refractory Rhabdomyosarcoma
  • Refractory Soft Tissue Sarcoma
  • Refractory Thyroid Gland Carcinoma
  • Refractory WHO Grade 2 Glioma
Interventions
  • DRUG
NCT04234841 | RECRUITING
750 participants

Avr Thrombosis OutcoMe Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-15
Start Date:
2020-02-01
Completion:
2028-01-31
Conditions
  • Aortic Stenosis
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT03819296 | RECRUITING | PHASE1
800 participants

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-15
Start Date:
2021-02-21
Completion:
2026-10-31
Conditions
  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • Clinical Stage IA Cutaneous Melanoma AJCC v8
  • Clinical Stage IB Cutaneous Melanoma AJCC v8
  • Clinical Stage II Cutaneous Melanoma AJCC v8
  • Clinical Stage IIA Cutaneous Melanoma AJCC v8
  • Clinical Stage IIB Cutaneous Melanoma AJCC v8
  • Clinical Stage IIC Cutaneous Melanoma AJCC v8
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Colitis
  • Lung Non-Small Cell Carcinoma
  • Malignant Genitourinary System Neoplasm
  • Malignant Solid Neoplasm
  • Pathologic Stage 0 Cutaneous Melanoma AJCC v8
  • Pathologic Stage I Cutaneous Melanoma AJCC v8
  • Pathologic Stage IA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IB Cutaneous Melanoma AJCC v8
  • Pathologic Stage II Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage III Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Stage 0 Lung Cancer AJCC v8
  • Stage I Lung Cancer AJCC v8
  • Stage IA1 Lung Cancer AJCC v8
  • Stage IA2 Lung Cancer AJCC v8
  • Stage IA3 Lung Cancer AJCC v8
  • Stage IB Lung Cancer AJCC v8
  • Stage II Lung Cancer AJCC v8
  • Stage IIA Lung Cancer AJCC v8
  • Stage IIB Lung Cancer AJCC v8
  • Stage III Lung Cancer AJCC v8
  • Stage IIIA Lung Cancer AJCC v8
  • Stage IIIB Lung Cancer AJCC v8
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • OTHER
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page